FOXM1 and small cell lung carcinoma: After observing the FOXM1-AURKB relationship in SCLC, specific AURKB inhibitor Barasertib was tested on SBC-3 cells which showed a very potent effect on this cell line, highlighting the importance of FOXM1-AURKB axis (supplementary Fig. S11A).